Both in Biotechnology
Kymera Therapeutics vs Krystal Biotech
Over the past year KYMR returned +116.4% and KRYS returned +53.8%; their daily moves had a correlation of 0.28.
KYMR +116.4% KRYS +53.8%Growth of $1, one year, split-adjusted
| Metric | KYMR | KRYS |
|---|---|---|
| Price | $129.23 | $304.24 |
| Market cap | $11.03B | $9.01B |
| Today | +1.35% | +2.82% |
| 1 month | +17.6% | −9.1% |
| 6 months | +56.2% | +6.9% |
| Year to date | +66.1% | +23.4% |
| 1 year | +109.0% | +54.0% |
| Revenue growth (YoY) | −100.0% | +30.2% |
| Gross margin | — | 94.1% |
| Net margin | — | 49.5% |
| P/E (TTM) | — | 40.0× |
| Price / sales | 107.9× | 19.2× |
| Net cash | $969.2M | $911.9M |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 38.9% |
| Short % of float | 13.7% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).